Our results showed that the protein levels of PRMT1 and H4R3me2a were specifically elevated in CML CD34+ cells but not CML CD34− cells (Figure 1D). This evidence concerns the gene PRMT1 and chronic myelogenous leukemia, BCR-ABL1 positive.